Cytokine |
Type of Progenitor Cell |
Experimental model used |
Role in proliferation |
Role in differentiation |
Role in survival |
Role in migration |
Notes |
Reference |
Pro-Inflammatory |
|
|
|
|
|
|
|
IL-1β |
eNPC, rat |
in vitro |
decreased |
increased astrocyte lineage |
decreased |
no effect |
SAPK/JNK pathway |
[13] |
|
aNPC, rat, SGZ |
in vitro |
decreased |
ND |
no effect |
ND |
Receptor subtype IL-1R1 |
[12] |
|
|
in vivo |
decreased |
ND |
no effect |
ND |
|
|
|
|
in vitro |
ND |
no effect |
ND |
ND |
|
[14] |
IL-1α |
eNPC, mouse |
in vitro |
ND |
increased astrocyte lineage |
no effect |
ND |
|
[17] |
IL-6 |
eNPC, mouse |
in vitro |
ND |
increased neurogenesis |
ND |
ND |
MAPK/CREB |
[22] |
|
|
|
|
increased gliogenesis |
|
|
STAT3 |
|
|
|
|
|
|
|
|
H-IL-6 only |
|
|
aNPC, human, SVZ & SGZ |
in vitro |
ND |
increased |
ND |
ND |
no effect on MHC expression |
[21] |
|
pnNPC, mouse, SGZ |
in vivo |
decreased |
decreased |
decreased |
no effect |
|
[20] |
|
aNPC, rat, SGZ |
in vitro |
decreased |
decreased |
decreased |
ND |
|
[14] |
TNF-α |
eNPC, rat |
in vitro |
decreased |
ND |
decreased |
ND |
|
[31] |
|
eNPC, rat |
in vitro |
ND |
increased |
decreased |
ND |
via activated microglia |
[32] |
|
aNPC, mouse, SVZ |
in vitro |
no effect |
no effect |
decreased |
ND |
|
[30] |
|
aNPC, rats, SVZ |
in vitro |
increased |
no effect |
decrease |
ND |
NfκB |
[29] |
|
aNPC, rat, SVZ |
in vivo |
increased |
ND |
no effect |
ND |
|
[28] |
|
pnNPC, rat, SVZ |
in vitro |
decreased |
no effect |
increased |
increased |
blocked IFN-γ |
[11] |
|
aNPC, mouse, SGZ |
in vivo |
decreased (TNFRI) |
decreased (TNFR1) |
increased (TNFRII) |
ND |
differed based on receptor |
[27] |
|
aNPC, rat, SGZ |
in vitro |
ND |
decreased |
ND |
ND |
|
[14] |
|
aNPC, human, SVZ & SGZ |
in vitro |
ND |
increased gliogenesis |
ND |
ND |
increased MHC expression |
[21] |
IL-18 |
eNPC, rat |
in vitro |
ND |
increased |
decreased |
ND |
|
[32] |
IL-2 |
eNPC, rat |
in vitro |
ND |
ND |
no effect |
ND |
|
[31] |
|
pnNPC, rat |
in vitro |
ND |
increased |
no effect |
ND |
|
[23] |
IFN-γ |
eNPC, rat |
in vitro |
decreased |
ND |
decreased |
ND |
|
[39] |
|
pnNPC, rat, SVZ |
in vitro |
decreased |
no effect |
decreased |
increased |
|
[11] |
|
aNPC, mouse, SVZ |
in vitro |
no effect |
increased |
ND |
ND |
via activated microglia |
[37] |
|
|
|
|
|
|
|
low levels |
|
|
aNPC, mouse, SVZ |
in vitro |
decreased |
increased |
no effect |
ND |
increased neurite branching |
[30] |
|
aNPC, human, SVZ & SGZ |
in vitro |
ND |
increased |
ND |
ND |
increased MHC expression |
[21] |
|
aNPC, rat, SGZ |
in vitro |
ND |
no effect |
ND |
ND |
|
[14] |
Anti-inflammatory |
|
|
|
|
|
|
|
IL-10 |
aNPC, mouse, SVZ |
in vitro |
ND |
ND |
ND |
increased |
upregulated chemokine receptors |
[45] |
|
aNPC, mouse, SVZ |
in vivo |
ND |
increased neurogenesis |
increased |
ND |
|
[42] |
|
|
|
|
increased oligodendrogenesis |
|
|
|
|
IL-4 |
aNPC, mouse, SVZ |
in vitro |
no effect |
increased oligodendrogenesis |
ND |
ND |
via activated microglia |
[37] |
|
aNPC, mouse, SVZ |
in vitro |
ND |
ND |
ND |
increased |
upregulated chemokine receptors |
[45] |
TGF-β |
aNPC, mouse, SVZ |
in vivo |
decreased |
no effect |
increased |
ND |
|
[51] |
|
|
in vitro |
decreased |
no effect |
increased |
ND |
|
|
|
aNPC, rat, SGZ |
in vivo |
decreased |
increased |
ND |
ND |
|
[48] |
|
|
in vitro |
decreased |
increased |
ND |
ND |
|
|
|
aNPC, rat, SGZ |
in vitro |
decreased |
ND |
no effect |
ND |
|
[47] |
|
aNPC, mouse, SGZ |
in vivo |
decreased |
ND |
decreased |
ND |
|
|
|
aNPC, mouse, SGZ |
in vivo |
decreased |
no effect |
increased |
ND |
|
[51] |
|
aNPC, mouse, SGZ |
in vivo |
increased |
increased |
increased |
ND |
|
[52] |
Unclassified |
|
|
|
|
|
|
|
|
IL-15 |
pnNPC, rat |
in vitro |
no effect |
decreased |
no effect |
ND |
MAP-2/STAT-3 |
[56] |
|
aNPC, mouse, SVZ |
in vitro |
increased |
decreased |
no effect |
ND |
|
[57] |
IL-7 |
eNPC, human |
in vitro |
ND |
increased neurogenesis |
ND |
increased |
|
[60] |
|
aNPC, human |
|
|
increased gliogenesis |
|
|
|
|
IL, interleukin; TNF-α, tumor necrosis factor-alpha; TGF-β, transforming growth factor-beta; NPC, neural progenitor cell; SGZ, subgranular zone; SVZ, subventricular zone;
ND, no data; eNPC, embryonic NPC; pnNPC, postnatal NPC; aNPC, adult NPC. |